StockData

Seaport Therapeutics, Inc. (SPTX) stock

SPTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026
$18.17−0.95 (-4.97%)

Close on Nov 17, 2026Market cap $972.65MP/E –Yield –

Seaport Therapeutics EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$0.49–
Q2 FY2026Jun 30, 2026-$1.78–
Q1 FY2026Mar 31, 2026-$10.34–
Q3 FY2025Sep 30, 2025-$9.43–
Q2 FY2025Jun 30, 2025-$6.40–
Q1 FY2025Mar 31, 2025-$5.65–

More Seaport Therapeutics figures

See a number that looks wrong?